Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.31 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2138160 | 1.00 | MAPT (0.38) | MAPTEPHX1ACE2CPB2GPR84 | |
| SCHEMBL2132708 | 0.98 | MAPT (0.35) | MAPTEPHX1ACE2 | |
| SCHEMBL2138765 | 0.90 | MAPT (0.38) | MAPTEPHX1ACE2CPB2GPR84 | |
| SCHEMBL2136920 | 0.88 | MAPT (0.35) | MAPTEPHX1ACE2 | |
| SCHEMBL2136786 | 0.85 | RNPEP (0.31) | MAPT | |
| SCHEMBL2135816 | 0.83 | MAPT (0.36) | MAPTEPHX1ACE2GPR84FFAR1 | |
| SCHEMBL2135036 | 0.82 | FOLH1 (0.33) | MAPTEPHX1 | |
| SCHEMBL2135156 | 0.82 | EPHX1 (0.37) | EPHX1CPB2 | |
| SCHEMBL2138208 | 0.82 | EPHX1 (0.44) | MAPTEPHX1ACE2CPB2GPR84 | |
| SCHEMBL2137090 | 0.82 | EPHX1 (0.37) | EPHX1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120101294-A1 | PROCESS FOR PRODUCING (FLUOROALKYLTHIO) ACETIC ACID ESTER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101294-A1 | PROCESS FOR PRODUCING (FLUOROALKYLTHIO) ACETIC ACID ESTER | GRHPR, AKR7A2, FAR1 | MAPT 4195/4885EPHX1 2018/4885ACE2 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.